Role of Alprazolam in the Management of Acute Coronary Syndrome
Status:
Recruiting
Trial end date:
2022-02-20
Target enrollment:
Participant gender:
Summary
Cardiovascular disease has always been one of the most concerning ailments of all times
considering mortality. On one end due to the emergence of pharmaceutical technology, there is
a reduction in mortality, on the other hand owing to a sedentary lifestyle the incidence of
this disease is increasing. Hence leading to up slopping trend in cardiovascular prevalence.
Acute coronary syndrome is one of the most deadly and acute presentations of cardiology
requiring immediate intervention to dampen the frequency of complications. One of the
fundamental goals in the treatment of ACS is to lower the heart rate so that load on
myocardial tissue can be reduced. In order to do so, we already have multiple options like
beta-blockers, calcium channel blockers, and new generation ivabradine (not affecting blood
pressure unlike others).